Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 810-818

  Manning, Carol D ^a   Mclaughlin, Megan M ^a   Livi, George P ^a   Cieslinski, Lenora B ^a   Torphy, Theodore J ^a   Barnette, Mary S ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; ISOENZYME; MESSENGER RNA;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HUMAN; MOLECULAR GENETICS; MONOCYTE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; UPREGULATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; BASE SEQUENCE; CELLS, CULTURED; CYCLIC AMP; GENE EXPRESSION; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; MONOCYTES; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; UP-REGULATION;

EID: 0030075351     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. D,). Gene 138: 253-256, 1994.
2. 2-adrenoceptor agonists in asthma. Trends Pharmacol Sci. 13: 20-23, 1992.
3. BEAVO, J. A. AND REIFSNYDER, D. H : Primary sequence of eyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11: 150-155, 1990.
4. BOLGER, G., MICHAELI, T., MARTINS, T., ST. JOHN, T., STEINER, B , RODGERS, L., RIGGS, M., WIGLER, M. AND FERGUSON, K.: A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mole. Cell. Biol. 13: 6558-6571, 1993.
5. BOURNE, H. R., LICHTENSTEIN, L. M., MELMON, K. L., HENNEY, C. S., WEINSTEIN, Y. AND SHEARER, G. M.: Modulation of inflammation and immunity by cyclic AMP. Science (Wash. DC) 184: 19-28, 1974.
6. BOURNE, H. R., TOMKINS, G. M. AND DION, S.: Regulation of phosphodiesterase synthesis: Requirement for cyclic adenosine monophosphate dependent protein kinase. Science (Wash. DC) 181: 952-954, 1973.
7. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
8. BROOKER, G., HARPER, J. F., TERASAK, W. L. AND MOYLAN, R. D.: Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic Nucleotide Res. 10: 1-19, 1979
9. CHAN, S. C., GREWE, S. R., STEVENS, S. R. AND HANIFIN, J. M.: Functional desensitization due to stimulation of cyclic AMP-phosphodiesterase in human mononuclear leukocytes J. Cyc. Nucleotide Res. 8: 211-224, 1982.
10. CHIRGWIN, J. J., PRZBYLA, A. E., MACDONALD, R. J. AND RUTTER, W. J.: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
11. CHOMCZYNSKI, P AND SACCHI, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
12. CONTI, M., TOSCANO, M. V., PETRELLI, L., GEREMIA, R. AND STEFANINI, M.: Involvement of phosphodiesterase in the refractoriness of the Sertoli cell. Endocrinology 113: 1845-1853, 1983.
13. CONTI, M., JIN, S.-L. C., MONACO, L., REPASKE, D. R. AND SWINNEN, J. V.: Hormonal regulation of cyclic nucleotide phosphodiesterases. Endoc. Rev. 12: 218-234, 1991.
14. DAVIS, C. W. AND DALY, J. W.: A simple direct assay of 3′,5′-cyclic nucleotide phosphodiesterase activity based on the use of polyacrylamide-boronate affinity gel chromatography. J. Cyc. Nucleotide Res. 5: 65-74, 1979
15. + gene. Proc. Natl. Acad. Sci. U.S.A. 86: 3604-3608, 1989.
16. DENT, G., GIEMBYCZ, M. A., RABE, K. F. AND BARNES, P J.: Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by "type IV"-selective PDE inhibitors. Br. J. Pharmacol. 103: 1339-1346, 1991.
17. ENGELS, P., FICHTEL, K. AND LUBBERT, H.: Expression and regulation of human and rat phosphodiesterase type IV isogenes. FEBS Lett. 350: 291-295, 1994.
18. GREWE, S. R., CHAN, S. C. AND HANIFIN, J. M : Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: A possible mechanism for cyclic AMP-agonist hyporesponsiveness. J. Allergy Clin. Immunol. 70: 452-457, 1982.
19. HOLDEN, C. A., CHAN, S. C. AND HANTFIN, J. M.: Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis. J. Invest. Dermatol. 87: 372-376, 1986.
20. HOLDEN, C. A., CHAN, S. C., NORRIS, S. AND HANIFIN, J. M.: Histamine induced elevation of cyclic AMP phosphodiesterase activity in human monocytes. Agents Actions 22: 36-42, 1987.
21. KAMMER, G. M.: The adenylate cyelase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 9: 222-229, 1988.
22. m, rolipram-sensitive cyclic AMP phosphodiesterase. Mole. Cell. Biol. 10: 2678-2686, 1990.
23. MCHALE, M. M., CIESLINSKI, L. B., ENG, W.-K., JOHNSON, R. K., TORPHY, T. J. AND LIVI, G P.: Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast. Mol. Pharmacol. 39: 109-113, 1991.
24. m, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain: Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA. J. Biol. Chem. 268: 6470-6476, 1993.
25. MILATOVICH, A., BOLGER, G., MICHAELI, T. AND FRANCKE, U.: Chromosome localizations of genes for five cAMP-specific phosphodiesterases in man and mouse. Som. Cell. Mole. Gen. 20: 75-86, 1994.
26. OBERNOLTE, R., BHAKTA, S., ALVAREZ, R., BACH, C., ZUPPAN, P., MULKINS, M., JARNAGIN, K. AND SHELTON, E.: The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family. Gene 129: 239-247, 1993.
27. PEACHELL, P T., UNDEM, B. J., SCHLEIMER, R. P., MACGLASHAN, D. W., JR., LICHTENSTEIN, L. M., CIESLINSKI, L. B. AND TORPHY, T. J.: Preliminary identification and role of phosphodiesterase isozymes in human basophils. J. Immunol. 248: 2503-2510, 1992.
28. SAIKI, R. K., GELFAND, D. H., STOFFEL, S., SCHARF, S. J., HIGUCHI, R., HORN, G. T., MULLIS, K. B. AND ERLICH, H. A., Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (Wash. DC) 239: 487-490, 1988.
29. SEARS, M R., TAYLOR, D R., PRINT, C. G., LAKE, C. D., LI, Q., FLANNERY, E M., YATES, D. M., LUCAS, M. K. AND HERBISON, G. P.: Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336: 1391-1396, 1990.
30. SETTE, C., IONA, S. AND CONTI, M.: The short-term activation of a rolipramsensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation. J. Biol. Chem. 269: 9245-9252, 1994a
31. SETTE, C., VICINI, E. AND CONTI, M.: The ratPDE3/TVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-dependent protein kinase. J. Biol. Chem. 269: 18271-18274, 1994b
32. SHAKUR, Y., PRYDE, J. G. AND HOUSLAY, M. D.: Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rohpram. Biochem. J. 292: 677-686, 1993.
33. SPITZER, W. O , SUISSA, S., ERNST, P., HORWITZ, R. I, HABBICK, B., COCKROFT, D., BOIVIN, J.-F , MCNUTT, M., BUIST, A. S. AND REBUCK, A. S.: The use of β-agonists and the risk of death and near death from asthma. N Engl. J. Med. 326: 501-506, 1992.
34. SWLNNEN, J. V., JOSEPH, D. R. AND CONTI, M.: Molecular cloning of rat homologues of the Drosophila melanogaster dunce cAMP phosphodiesterase: Evidence for a family of genes. Proc. Natl. Acad. Sci. U.S.A. 86: 5325-5329, 1989a.
35. SWINNEN, J. V., D'SOUZA, B., CONTI, M. AND ASCOLI, M.: Attenuation of cAMP-mediated responses in MA-10 Leydig tumor cells by genetic manipulation of a cAMP-phosphodiesterase. J. Biol. Chem. 266: 14383-14389, 1991a.
36. SWINNEN, J. V., JOSEPH, D. R. AND CONTI, M.: The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP. Proc. Natl. Acad. Sci. U.S.A. 86: 8197-8201, 1989b
37. SWINNEN, J. V., TSIKALAS, K. E. AND CONTI, M.: Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell. J. Biol. Chem. 266: 18370-18377, 1991b.
38. THOMPSON, W. J., Ross, C. P., PLEDGER, W. J., STRADA, S., BANNER, R. L. AND HERSH, E. M. Cyclic adenosine 3′,5′-monophosphate phosphodiesterase. Distinet forms in human lymphocytes and monocytes. J. Biol. Chem. 251: 4922-4929, 1976.
39. TORPHY, T. J. AND UNDEM, B. J.: Phosphodiesterase inhibitors: New opportunities for the treatment of asthma. Thorax 46: 512-523, 1991.
40. TORPHY, T. J., ZHOU, H.-L. AND CIESLINSKI, L. B.: Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J. Pharm Exp. Ther. 263: 1195-1205, 1992.
41. 2: Implications for the therapeutic use of β-adrenoceptor agonists. J. Biol. Chem. 270: 23598-23604, 1995.
42. VERGHESE, M. W., MCCONNELL, R. T., LENHARD, J. M., HAMACHER, L. AND JIN, S.-L. C.: Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mole. Pharm. 47: 1164-1171, 1995.